The government is also seeking to dilute the authority of key agencies that decide the list and price of essential drugs, according to the report
By Rimin Dutt, The Huffington Post | October 4, 2016
In a move that could potentially result in higher prices of many essential drugs, the Indian government is considering a review of its current drug price control policy to encourage private investments in the sector, Economic Times reported.
The policy changing move, which is seeking to dilute the authority of the current drug price setting authorities, has backing from the Prime Minister’s Office, according to the report.
The senior official told ET, Central Drugs Standard Control Organisation, a key agency that regulates essential drugs, should not alone decide the list of essential drugs, and National Pharmaceutical Pricing Authority (NPPA), the agency responsible for setting the price of drugs, should not decide prices of all the essential drugs.